SciDev

Undervalued Micro-Cap: SciDev Positioned to Capitalize on PFAS Water Treatment Boom and Pro-Oil Momentum

Bigchase

Not Invested

Community Contributor

Published

27 Nov 24

Bigchase's Fair Value

AU$0.65

46.2% undervalued

27 Nov

AU$0.35

-38.1%

11.1%

-38.1%

11.1%

You can edit this narrative until May 14 2:36 AM. Then, changes will post as Updates.

Author's Valuation

AU$0.7

46.2% undervalued

Bigchase's Fair Value

Narrative

Updates0

Bigchase'sFair Value

AU$0.65

46.2% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

14.66%

Chemicals revenue growth rate

0.68%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.09%

Calculation

AU$3.51m

Earnings '29

48.45x

PE Ratio '29

AU$169.82m

Market Cap '29

AU$169.82m

Market Cap '29

189.85m

No. shares '29

AU$0.89

Share Price '29

AU$0.89 Share Price '29

Discounted to 2024 @ 6.50% p.a.

AU$0.65

Fair Value '24